Related Experiment Video
Updated: Jul 19, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
[Recent considerations of cardiogenic shock associated to the acute coronary ischemic syndromes]
1De la Unidad Coronaria del Instituto Nacional de Cardiología Ignacio Chávez", Becario del CONACYT, Tlalpan 14080, DF México.
Insights
This review explores cardiogenic shock in acute coronary syndromes, detailing complex neuro-hormonal and inflammatory changes. It proposes intensive pharmacotherapy to stabilize patients and reduce myocardial ischemia.
Area of Science:
- Cardiology
- Pathophysiology
- Pharmacology
Context:
- Cardiogenic shock complicates acute coronary syndromes.
- Pathophysiology involves complex neuro-hormonal, immuno-inflammatory, and biomolecular alterations.
- Understanding these mechanisms is crucial for effective treatment.
Purpose:
- To review the novel physiopathological concept of cardiogenic shock in acute coronary syndromes.
- To elucidate the intricate neuro-hormonal, immuno-inflammatory, and biomolecular changes.
- To incorporate the incidence of cardiogenic shock in the Mexican population.
Summary:
- Presents a novel physiopathological concept of cardiogenic shock linked to acute coronary syndromes.
- Highlights the complex interplay of neuro-hormonal, immuno-inflammatory, and biomolecular alterations.
- Discusses pharmacointensive treatment strategies for stabilization and myocardial ischemia reduction.
Impact:
- Aims to guide pharmacointensive treatment for acute coronary syndromes with cardiogenic shock.
- Contributes to reducing myocardial ischemia and improving patient outcomes.
- Provides insights into the specific incidence and implications for the Mexican population.
Abstract:
We review novel physiopathological concept of Cardiogenic Shock associated to acute coronary ischemic syndromes, where the mechanist terms become jumbled not only, but the neuro-hormonal, immuno-inflammatory, and biomolecular alterations. In order to offer a pharmacointensive treatment that obtains the stabilization of the acute coronary Syndrome, for the reduction of myocardial ischemia. Also, we incorporate the incidence of this pathology in the Mexican population.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Introduction Cardiac Emergencies
Acute Coronary Syndrome V: Nursing Management
